Overview
Flamingo Therapeutics works on therapeutic approaches to cancer, a field where novel mechanisms of action and targeted delivery continue to produce clinically meaningful advances. The company is part of the PMV investment portfolio, which has been actively building the Flemish biotech ecosystem alongside other holdings such as Augustine Therapeutics.
Key people
Alumni 1 went on to found or lead
Michael GarrettChief Operating Officer→Chief Executive Officer at ExeVir- PStephane Van RooijenChief Executive Officer→Mentor - volunteering at Termeer Institute
Backers
PMV (ParticipatieMaatschappij Vlaanderen)
Flemish government investment arm with a EUR 1.9B portfolio, backing tech and biotech companies with tickets up to EUR 20M.
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.